We are live on
!
Find out more
TCIM
TIAA CREF Investment Management Portfolio holdings
AUM
$141B
1-Year Est. Return
14.18%
This Fund
S&P 500
This Quarter
Est. Return
-13.82%
1 Year Est. Return
+14.18%
3 Year Est. Return
+70.08%
5 Year Est. Return
+108.37%
10 Year Est. Return
–
AUM
$126B
AUM Growth
-$26.9B
(-18%)
Cap. Flow
-$3.01B
Cap. Flow
% of AUM
-2.39%
Top 10 Holdings %
Top 10 Hldgs %
19.4%
Holding
3,092
New
38
Increased
894
Reduced
1,823
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$534M |
| 2 |
Meta Platforms (Facebook)
META
|
+$198M |
| 3 |
Procter & Gamble
PG
|
+$186M |
| 4 |
Chevron
CVX
|
+$182M |
| 5 |
Wells Fargo
WFC
|
+$173M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$335M |
| 2 |
PX
Praxair Inc
PX
|
+$329M |
| 3 |
AET
Aetna Inc
AET
|
+$251M |
| 4 |
FedEx
FDX
|
+$206M |
| 5 |
Amazon
AMZN
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.73% |
| 2 | Healthcare | 14.8% |
| 3 | Financials | 14.65% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
John B. Sanfilippo & Son
JBSS
$978M
| $945K | ﹤0.01% |
16,979
-97
| -0.6% | -$6.26K |
|
|
FLXN
2302
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $945K | ﹤0.01% |
83,447
-1,623
| -2% | -$25.4K |
|
|
TBRG
2303
DELISTED
TruBridge
TBRG
| $944K | ﹤0.01% |
37,607
| – | – |
|
2304
PetMed Express
PETS
$42.3M
| $942K | ﹤0.01% |
40,483
-261
| -0.6% | -$6.97K |
|
2305
Biglari Holdings Class B
BH
$1.2B
| $940K | ﹤0.01% |
8,275
+2,260
| +38% | +$333K |
|
2306
GoPro
GPRO
$107M
| $939K | ﹤0.01% |
221,351
-7,338
| -3% | -$41K |
|
2307
Frontline
FRO
$8.49B
| $938K | ﹤0.01% |
169,680
+6,313
| +4% | +$41.2K |
|
|
ZIXI
2308
DELISTED
Zix Corporation
ZIXI
| $937K | ﹤0.01% |
163,485
-434
| -0.3% | -$2.59K |
|
2309
Mercantile Bank Corp
MBWM
$1.05B
| $934K | ﹤0.01% |
33,040
-26,899
| -45% | -$834K |
|
|
ATHX
2310
DELISTED
Athersys, Inc. Common Stock
ATHX
| $932K | ﹤0.01% |
25,892
+7,423
| +40% | +$354K |
|
|
VIA
2311
DELISTED
Viacom Inc. Class A
VIA
| $931K | ﹤0.01% |
33,462
+7,937
| +31% | +$271K |
|
2312
Bristow Group
VTOL
$1.37B
| $930K | ﹤0.01% |
53,214
-25,579
| -32% | -$549K |
|
|
PRTY
2313
DELISTED
Party City Holdco Inc.
PRTY
| $929K | ﹤0.01% |
93,121
-144,715
| -61% | -$1.57M |
|
2314
FB Financial Corp
FBK
$3.07B
| $926K | ﹤0.01% |
26,432
-122
| -0.5% | -$4.47K |
|
|
APLS
2315
DELISTED
Apellis Pharmaceuticals
APLS
| $925K | ﹤0.01% |
70,112
-2,054
| -3% | -$31.5K |
|
2316
Forrester Research
FORR
$225M
| $922K | ﹤0.01% |
20,635
-125
| -0.6% | -$5.33K |
|
2317
Radware
RDWR
$1.2B
| $917K | ﹤0.01% |
40,358
-67,640
| -63% | -$1.56M |
|
2318
Aclaris Therapeutics
ACRS
$871M
| $916K | ﹤0.01% |
123,941
-58,578
| -32% | -$604K |
|
2319
Accuray
ARAY
$34.6M
| $914K | ﹤0.01% |
268,167
+53,053
| +25% | +$215K |
|
2320
Option Care Health
OPCH
$3.61B
| $914K | ﹤0.01% |
64,006
-1,602
| -2% | -$21.1K |
|
|
STML
2321
DELISTED
Stemline Therapeutics, Inc.
STML
| $913K | ﹤0.01% |
96,116
+45,387
| +89% | +$589K |
|
2322
Lexicon Pharmaceuticals
LXRX
$1.08B
| $911K | ﹤0.01% |
137,267
-26,100
| -16% | -$211K |
|
2323
Dime Commercial Bancshares
DCOM
$1.79B
| $908K | ﹤0.01% |
35,610
-3,931
| -10% | -$115K |
|
|
ALTA
2324
DELISTED
Altabancorp
ALTA
| $902K | ﹤0.01% |
29,905
-310
| -1% | -$9.88K |
|
2325
Tredegar Corp
TG
$275M
| $889K | ﹤0.01% |
56,045
| – | – |
|
Similar funds
TA
O
HFS
SBAM
BB
SA
WF
BCPEM
TIAA CREF Investment Management's Q4 2018 Portfolio in Review
As of Q4 2018, TIAA CREF Investment Management held 3,092 positions worth $126B, down 18% from $153B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 4%. TIAA CREF Investment Management opened 38 new positions and exited 85, leaving the 3,092-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- TIAA CREF Investment Management's largest Q4 2018 buy was Linde: 3,376,089 shares worth $527M.
- TIAA CREF Investment Management added most to Meta Platforms (Facebook) in Q4 2018, an estimated $198M increase.
- TIAA CREF Investment Management's biggest Q4 2018 reduction was Apple, cutting an estimated $335M.
- TIAA CREF Investment Management fully exited Praxair Inc in Q4 2018, selling an estimated $329M.
- TIAA CREF Investment Management's ten largest holdings make up 19% of its $126B portfolio in Q4 2018.
- TIAA CREF Investment Management opened 38 new positions and closed 85 in Q4 2018.
- TIAA CREF Investment Management's portfolio value fell 18% quarter-over-quarter to $126B.
Based on TIAA CREF Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.